Farther Finance Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.9K | Sell |
662
-216
| -25% | -$7.14K | ﹤0.01% | 2620 |
|
|
2025
Q1 | $32.9K | Sell |
878
-137
| -13% | -$5.14K | ﹤0.01% | 2118 |
|
|
2024
Q4 | $47.7K | Sell |
1,015
-64
| -6% | -$3.01K | ﹤0.01% | 1680 |
|
|
2024
Q3 | $57K | Sell |
1,079
-181
| -14% | -$9.56K | ﹤0.01% | 1577 |
|
|
2024
Q2 | $68.9K | Buy |
1,260
+24
| +2% | +$1.31K | ﹤0.01% | 1274 |
|
|
2024
Q1 | $90.3K | Buy |
1,236
+65
| +6% | +$4.75K | 0.01% | 976 |
|
|
2023
Q4 | $97.8K | Sell |
1,171
-133
| -10% | -$11.1K | 0.01% | 810 |
|
|
2023
Q3 | $38.4K | Buy |
1,304
+52
| +4% | +$1.53K | 0.01% | 860 |
|
|
2023
Q2 | $40.8K | Sell |
1,252
-476
| -28% | -$15.5K | 0.01% | 737 |
|
|
2023
Q1 | $60.8K | Buy |
+1,728
| New | +$60.8K | 0.02% | 548 |
|